Students

Santiago Acero Bedoya

Research Description:
My work focuses on activating and leveraging the immune system to elicit anti-tumor immunity with a special focus on increasing the efficacy of established immunotherapies.
Advisor(s):
Thomas Gajewski

Juan Apiz

Research Description:
Studying how cancer cells adapt to and survive under the nutritional context of the tumor microenvironment (TME). Building a multi-omics based metabolic profile of pancreatic ductal adenocarcinoma (PDAC) cells under TME nutrient levels.
Advisor(s):
Alexander Muir

Stephen Arnovitz

Matriculation Year :
2015

Briana Banks

Matriculation Year:
2019
Advisor(s):
Matthew Brady

Eric Bueter

Research Description:
Working at the interface of the research lab and clinic, our group is identifying mechanisms of resistance to anti-androgen therapies in advanced prostate cancer and translating these discoveries into improved treatment strategies for patients.
Advisor(s):
Russell Szmulewitz

Chufan Cai

Research Description:
Science interests: PDAC tumor; whether and which metabolite(s) in TME cause immunosuppression to T cells; Stress response: whether ATF4 is important for cancer growth
Advisor(s):
Alex Muir

Deniz Nesli Dolcen

Research Description:
Focusing on determining how m6A mRNA modification translationally regulates triple-negative breast cancer gene expression.
Advisor(s):
Suzanne Conzen

Maria Evers

Research Description:
My previous research at Ohio University investigated ATP as a modulator of epithelial to mesenchymal transition / metastasis in lung cancer. My current research interests are in blood cancers, cancer immunology, cancer metabolism, and metastasis.

Robert Gruener

Research Description:
My work investigates statistical modeling approaches for drug prediction and drug discovery. By contextualizing patterns of cell line drug response in patients, we aim to predict and evaluate drugs effective in triple-negative breast cancers

Katrina M. Hawley

Research Description:
Exploring stapled peptides as a tool for interrupting protein-protein interactions in order to manipulate the immune system with the overall goal of improving existing immunotherapies and generating new strategies for the treatment of cancer.
Advisor(s):
James LaBelle